News

Genomines, a biotech company pioneering biobased metal extraction, has raised over $45 million in a Series A funding round. This oversubscribed raise signals a shift in how the world will source ...
The era of digital twins offers a future where deep biology, AI and real-world data combine to make medicine more personal, ...
Genetic editing holds promise to treat incurable diseases, but the most popular method - CRISPR - sometimes does more harm ...